News

The investment round, valued at close to 100 million renminbi, or $13.8 million, was led by L'Oréal's China fund, its ...
Dr. Aaron Carrithers brings a founder’s mindset and extensive firsthand experience, guiding biotech teams through complicated ...
Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...
The Beachwood-based company announced on Tuesday, May 20, that it has appointed Dr. David Llewellyn as its new CEO and as a ...
Q1 2025 Earnings Call Transcript May 21, 2025 Evogene Ltd. beats earnings expectations. Reported EPS is $-0.38, expectations ...
Cuts to funding risk hobbling Boston’s science establishment ...
Thermo Fisher Scientific, a Massachusetts-based CDMO giant, inked a collaboration deal with biotech startup Mirai Bio to ...
Skanska, a project development and construction group, has been awarded a contract by the Norwegian Road Authority to ...
Biotechs have faced several challenging years with slumping valuations and a competitive funding environment. However, the latest slew of ...
Developed by ALX Oncology's protein engineers utilizing the Company's proprietary topoisomerase I inhibitor payload and ...
Operator: Good afternoon, and welcome to Oncolytics Biotech First Quarter Conference Call. All participants are in a listen-only mode.